Compare NPCT & NATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NPCT | NATR |
|---|---|---|
| Founded | 2020 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 306.8M | 389.1M |
| IPO Year | N/A | N/A |
| Metric | NPCT | NATR |
|---|---|---|
| Price | $10.27 | $21.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $21.33 |
| AVG Volume (30 Days) | ★ 107.1K | 107.1K |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | ★ 9.82% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.80 |
| Revenue | N/A | ★ $474,542,000.00 |
| Revenue This Year | N/A | $7.30 |
| Revenue Next Year | N/A | $3.44 |
| P/E Ratio | ★ N/A | $27.16 |
| Revenue Growth | N/A | ★ 6.62 |
| 52 Week Low | $8.58 | $11.01 |
| 52 Week High | $10.63 | $24.12 |
| Indicator | NPCT | NATR |
|---|---|---|
| Relative Strength Index (RSI) | 41.03 | 55.86 |
| Support Level | $10.16 | $21.42 |
| Resistance Level | $10.26 | $23.03 |
| Average True Range (ATR) | 0.09 | 0.82 |
| MACD | 0.00 | -0.25 |
| Stochastic Oscillator | 35.14 | 28.03 |
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to seek total return through high current income and capital appreciation, while giving special consideration to certain impact and environmental, social and governance criteria.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.